why Intellia Therapeutics Inc [NTLA] is a Good Choice for Investors After New Price Target of $59.08
Intellia Therapeutics Inc [NASDAQ: NTLA] slipped around -1.01 points on Wednesday, while shares priced at $13.12 at the close of the session, down -7.15%. Compared to the average trading volume of 2.10M shares, NTLA reached a trading volume of 4452393 in the most recent trading